CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale Chief Commercial Ofc Imm Med sold 44,665 shares at an average $6.98 ($311,792)
- 4 Open-market sale Chief Financial Officer sold 10,320 shares at an average $6.98 ($72,072)
- 4 Open-market sale President and COO sold 59,505 shares at an average $6.98 ($415,540)
- 4 Open-market sale Chief Scientific Officer sold 96,656 shares at an average $6.99 ($675,219)
- 4 Open-market sale CEO and Chairman sold 219,569 shares at an average $7.29 ($1,600,417)
- 4 Grant or award Director acquired 15,394 shares (grant or award)
- 4 Grant or award Director acquired 15,394 shares (grant or award)
- 4 Grant or award Director acquired 15,394 shares (grant or award)
- 4 Grant or award Director acquired 15,394 shares (grant or award)
- 4 Planned sale Director sold 15,664 shares at $7.94 ($124,372)
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 4 Planned sale CEO and Chairman sold 285,187 shares at an average $8.45 ($2,410,700)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CEO and Chairman sold 470,368 shares at an average $8.47 ($3,985,754)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
Page 12 of 42 · 836 filings